J Gynecol Oncol.  2020 Jul;31(4):e68. 10.3802/jgo.2020.31.e68.

Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists

  • 1Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China
  • 2Department of Gynecology, Qilu Hospital of Shandong University, Jinan, China
  • 3Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China
  • 4Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
  • 5Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 6Department of Obstetrics and Gynecology, The Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China
  • 7Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China
  • 8Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
  • 9Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 10Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • 11Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • 12Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
  • 13Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, Chengdu, China
  • 14Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 15Department of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China


The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.


COVID-19; Gynecological Malignancies; Pandemic; Management; Recommendations
Full Text Links
  • JGO
export Copy
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error